Burning Rock Biotech Limited announced the resignation of Dr. Shaokun (Shannon) Chuai as a director from the board of directors of the Company and as the Companyâs Chief Scientific Officer, effective June 30, 2023. Dr. Shaokun (Shannon) Chuai will continue to serve as a senior advisor to the Company. Dr. Zhihong (Joe) Zhang, the Companyâs Chief Technology Officer since March 2016, has been appointed as a new director of the Board, effective June 30, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.49 USD | +4.76% | -0.79% | -19.46% |
1st Jan change | Capi. | |
---|---|---|
-19.46% | 76.84M | |
-24.41% | 7.76B | |
+67.56% | 4.35B | |
+2.59% | 2.67B | |
-2.45% | 2.64B | |
-47.56% | 2.1B | |
-17.86% | 1.73B | |
-19.62% | 1.52B | |
+12.59% | 1.18B | |
-45.36% | 1.11B |
- Stock Market
- Equities
- BNR Stock
- News Burning Rock Biotech Limited
- Burning Rock Biotech Limited Announces Management Changes, Effective June 30, 2023